President & Immunovant CEO
Fri, May 22, 2026
May 22
200,000 shares @ $3.85
Increased holdings by +12.40%
89th largest trade (out of 285)
Trade made by an officer
10b5-1 scheduled trade
32% win rate · -6.0% median edge vs SPY (85 trades, 90-day)
Insider trade was 87% below market price
Price 36% above 200-day moving average